Výsledky vyhledávání

Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies

Autor: Broadhurst, D, Goodacre, R, Reinke, SN, Kuligowski, J, Wilson, ID, Lewis, MR, Dunn, WB

Publikováno v: Metabolomics
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Background Quality assurance (QA) and quality control (QC) are two quality management processes that are integral to the success of metabolomics including their application for the acquisition of high quality data in any high-throughput analytical ch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c2e714e6272fabb03860a4ba46e2bc61
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8574

Zobrazit plný text záznamu

AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome

Autor: O'Reilly, MW, Kempegowda, P, Walsh, M, Taylor, AE, Manolopoulos, KN, Allwood, JW, Semple, RK, Hebenstreit, D, Dunn, WB, Tomlinson, JW, Arlt, W

Publikováno v: O'Reilly, M W, Kempegowda, P, Walsh, M, Taylor, A E, Manolopoulos, K N, Allwood, J W, Semple, R K, Hebenstreit, D, Dunn, W B, Tomlinson, J W & Arlt, W 2017, ' AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome ', Journal of Clinical Endocrinology & Metabolism, vol. 102, no. 9, pp. 3327-3339 . https://doi.org/10.1210/jc.2017-00947
The Journal of Clinical Endocrinology and Metabolism

Context: Polycystic ovary syndrome (PCOS) is a prevalent metabolic disorder, occurring in up to 10% of women of reproductive age. PCOS is associated with insulin resistance and cardiovascular risk. Androgen excess is a defining feature of PCOS and ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e337e158f2de3f07a0b1a2bb2700fa3
https://www.pure.ed.ac.uk/ws/files/50469407/jc.2017_00947.pdf

Zobrazit plný text záznamu

The future of metabolomics in ELIXIR

Publikováno v: F1000Research
F1000Research, 2017, 6 (Version 2), ⟨10.12688/f1000research.12342.2⟩
Repisalud
Instituto de Salud Carlos III (ISCIII)
F1000Research, Faculty of 1000, 2017, 6, ⟨10.12688/f1000research.12342.1⟩
F1000Research, 6, 1649
F1000Research, 6:1649. F1000 Research Ltd.
F1000Research, Faculty of 1000, 2017, 6 (Version 2), ⟨10.12688/f1000research.12342.2⟩
HAL Clermont Université
HAL-CEA
Hal-Diderot
Spiral-Imperial College Digital Repository
Hyper Article en Ligne
UnpayWall
ORCID
HAL-Inserm
HAL-UPEC / UPEM
HAL-Pasteur
Mémoires en Sciences de l'Information et de la Communication
HAL Descartes
F1000Research, 6

We are grateful to the proteomics community for sharing their experiences from their meeting “The future of proteomics in ELIXIR” on March 1–2 2017 in Tübingen, allowing us to build on this and organise our workshop as a one-day event.The meet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ffb84004904b403858cfc4bb146b8f
http://hdl.handle.net/2158/1101245

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání